Related Experiment Video

Updated: May 21, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Latest in cystic fibrosis

Ravi P Nayak1

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Saint Louis University School of Medicine, USA. nayakrp@slu.edu

Missouri Medicine
|June 9, 2012
PubMed

Insights

Cystic Fibrosis (CF) is a genetic disorder caused by CFTR gene mutations. Advances in understanding and treatment have significantly increased the life expectancy for CF patients.

Area of Science:

  • Genetics
  • Pulmonology
  • Medical Science

Background:

  • Cystic Fibrosis (CF) is a multi-organ genetic disease.
  • Approximately 30,000 individuals in the US are affected by CF.
  • CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and its protein.

Purpose of the Study:

  • To review the current understanding of Cystic Fibrosis.
  • To highlight recent therapeutic advances in CF treatment.
  • To discuss the impact of these advances on patient life expectancy.

Main Methods:

  • Literature review of genetic CF research.
  • Analysis of epidemiological data for CF patients in the US.
  • Examination of recent clinical trial outcomes for CF therapies.

Main Results:

  • CFTR gene mutations are the primary cause of Cystic Fibrosis.
  • Therapeutic progress has led to improved treatment outcomes.
  • Life expectancy for CF patients has risen to the late 30s.

Conclusions:

  • Continued research and therapeutic innovation are crucial for CF.
  • Enhanced understanding of CFTR function improves treatment strategies.
  • The outlook for individuals with Cystic Fibrosis has significantly improved.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation